CN103071112B - Traditional Chinese medicine for curing nasopharynx cancer - Google Patents
Traditional Chinese medicine for curing nasopharynx cancer Download PDFInfo
- Publication number
- CN103071112B CN103071112B CN201310001820.8A CN201310001820A CN103071112B CN 103071112 B CN103071112 B CN 103071112B CN 201310001820 A CN201310001820 A CN 201310001820A CN 103071112 B CN103071112 B CN 103071112B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for curing nasopharynx cancer, which is composed of the following raw materials by weight: 8 to 12 parts of root of wild grape, 13 to 17 parts of immature bitter orange, 28 to 32 parts of fiveleaf akebia fruit, 4 to 15 parts of ginseng, 4 to 15 parts of conic gymnadenia tuber, 13 to 17 parts of coptis, 8 to 12 parts of trogopterus dung, 28 to 32 parts of mock-strawberry, 8 to 12 parts of small red garlic root, 13 to 17 parts of ligusticum wallichii, 4 to 15 parts of rhizoma sparganii, 13 to 17 parts of curcuma zedoary, 28 to 32 parts of huechys, 4 to 15 parts of aristolochia cinnabarina, 8 to 12 parts of artemisia anomala, 28 to 32 parts of radix tinosporae, 1 to 5 parts of cordate houttuynia, 8 to 12 parts of abelmosk, 4 to 15 parts of stony living aster, 1 to 5 parts of catharanthus roseus, 28 to 32 parts of apiary and 13 to 17 parts of perfoliote knotweed herb. Based on the principle of supporting body resistance, herbal formulas with functions of reinforcing qi, nourishing blood, promoting blood circulation to remove blood stasis, clearing away heat and toxic materials, relieving swelling and pain and the like are adopted, so that for patients suffering with nasopharynx cancer, the traditional Chinese medicine has the advantage of good curative effect, and takes effect quickly.
Description
technical field:
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine for the treatment of nasopharyngeal carcinoma.
background technology:
Nasopharyngeal carcinoma refers to the malignant tumor that betides cavum nasopharyngeum top and sidewall.Be one of China's malignant tumor occurred frequently, sickness rate is first of ear,nose & throat malignant tumor.Common symptoms is for being with blood, ear suffocation sense, auditory dysesthesia, diplopia and headache etc. in nasal obstruction, tears.
At present, the field of Chinese medicines for the treatment of nasopharyngeal carcinoma has the following disadvantages: one, effect is obvious not; Two, take effect slow, can not timely and effective inhibition throat tumor growth, transfer, diffusion.
summary of the invention:
The object of the invention is exactly the defect in order to make up prior art, and a kind of Chinese medicine for the treatment of nasopharyngeal carcinoma is provided, and it has advantages of, and curative effect is obvious, instant effect.
The present invention is achieved by the following technical solutions:
A Chinese medicine for the treatment of nasopharyngeal carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix vitis romanetii 8-12, Fructus Aurantii Immaturus 13-17, Fructus Akebiae 28-32, Radix Ginseng 4-15, Rhizoma Gymnadeniae 4-15, Rhizoma Coptidis 13-17, Oletum Trogopterori 8-12, Herba Duchesneae Indicae 28-32, little red Bulbus Allii root 8-12, Rhizoma Chuanxiong 13-17, Rhizoma Sparganii 4-15, Rhizoma Curcumae 13-17, huechys 28-32, Radix Aristolochiae Kaempferi 4-15, Herba Artemisiae Anomalae 8-12, Radix Tinosporae 28-32, Herba Houttuyniae 1-5, Radix seu folium abelmoschi moschati 8-12, Aster oreophilus Franch 4-15, Herba Catharanthi Rosei 1-5, Nidus Vespae 28-32, Herba Polygoni cymosi 13-17.
A Chinese medicine for the treatment of nasopharyngeal carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix vitis romanetii 10, Fructus Aurantii Immaturus 15, Fructus Akebiae 30, Radix Ginseng 6, Rhizoma Gymnadeniae 6, Rhizoma Coptidis 15, Oletum Trogopterori 10, Herba Duchesneae Indicae 30, little red Bulbus Allii root 10, Rhizoma Chuanxiong 15, Rhizoma Sparganii 6, Rhizoma Curcumae 15, huechys 30, Radix Aristolochiae Kaempferi 6, Herba Artemisiae Anomalae 10, Radix Tinosporae 30, Herba Houttuyniae 3, Radix seu folium abelmoschi moschati 10, Aster oreophilus Franch 6, Herba Catharanthi Rosei 3, Nidus Vespae 30, Herba Polygoni cymosi 15.
Advantage of the present invention is:
Chinese medicine of the present invention, in line with the principle of the body resistance strengthening and constitution consolidating, adopts the Chinese medicine formulas such as benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, has good effect, the advantage of instant effect for Nasopharyngeal Carcinoma Patients.
the specific embodiment:
Treat a Chinese medicine for nasopharyngeal carcinoma, the weight (g) of its each raw material components is: Radix vitis romanetii 10, Fructus Aurantii Immaturus 15, Fructus Akebiae 30, Radix Ginseng 6, Rhizoma Gymnadeniae 6, Rhizoma Coptidis 15, Oletum Trogopterori 10, Herba Duchesneae Indicae 30, little red Bulbus Allii root 10, Rhizoma Chuanxiong 15, Rhizoma Sparganii 6, Rhizoma Curcumae 15, huechys 30, Radix Aristolochiae Kaempferi 6, Herba Artemisiae Anomalae 10, Radix Tinosporae 30, Herba Houttuyniae 3, Radix seu folium abelmoschi moschati 10, Aster oreophilus Franch 6, Herba Catharanthi Rosei 3, Nidus Vespae 30, Herba Polygoni cymosi 15.
Take above raw material components, according to the routine fashion of decoction, add water and boil decoction and take, every day potion, potion is taken at twice.
For proving that the present invention has good curative effect, enumerate model case as follows:
Case one:
Lee, 49 years old, found to be with the blood streak in nasal mucus in April, 2010, starts to think the epistaxis of getting angry and causing, still, occurred afterwards cough, hoarseness, the health symptom such as become thin.Carry out nasopharyngeal endoscope and biopsy to hospital afterwards, be finally diagnosed as nasopharyngeal carcinoma.Give treatment by Chinese herbs of the present invention, take after one month, cough is clearly better; Continue to take two months, weight in patients increases, and the state of an illness is clearly better.
Case two:
Huang, man, 52 years old.Main suit: epistaxis is also with symptoms such as tinnitus.Be diagnosed as nasopharyngeal carcinoma to examination in hospital.Hospital gives radiotherapy in the treatment, but DeGrain, and patient starts to occur the symptoms such as headache.After give Chinese medicine of the present invention, after first quarter moon, headache transference cure; Take continuously one and a half months, nasopharynx part lump obviously dwindles; Continue to take half a year, patient's nasopharynx part lump disappears, and conditions of patients is stable.
Case three:
Wang, female, 50 years old.In JIUYUE, 2011, because epistaxis to examination in hospital is diagnosed as nasopharyngeal carcinoma.It is carried out to chemotherapeutic treatment, and after chemotherapy there is the side effect such as lethargy, headache, stomach discomfort in patient.After change into and take Chinese medicine of the present invention.After first quarter moon, patient's spirit is clearly better; Continue to take one month, lump reduces to some extent; Take so far, conditions of patients is stable always.
Claims (2)
1. a Chinese medicine for the treatment of nasopharyngeal carcinoma, is characterized in that: the weight proportion of its each raw material components is: Radix vitis romanetii 8-12, Fructus Aurantii Immaturus 13-17, Fructus Akebiae 28-32, Radix Ginseng 4-15, Rhizoma Gymnadeniae 4-15, Rhizoma Coptidis 13-17, Oletum Trogopterori 8-12, Herba Duchesneae Indicae 28-32, little red Bulbus Allii root 8-12, Rhizoma Chuanxiong 13-17, Rhizoma Sparganii 4-15, Rhizoma Curcumae 13-17, Huechys sanguinea De Geer. 28-32, Radix Aristolochiae Kaempferi 4-15, Herba Artemisiae Anomalae 8-12, Radix Tinosporae 28-32, Herba Houttuyniae 1-5, Radix seu folium abelmoschi moschati 8-12, Aster oreophilus Franch 4-15, Herba Catharanthi Rosei 1-5, Nidus Vespae 28-32, Herba Polygoni cymosi 13-17.
2. a kind of Chinese medicine for the treatment of nasopharyngeal carcinoma according to claim 1, is characterized in that: the weight proportion of its each raw material components is: Radix vitis romanetii 10, Fructus Aurantii Immaturus 15, Fructus Akebiae 30, Radix Ginseng 6, Rhizoma Gymnadeniae 6, Rhizoma Coptidis 15, Oletum Trogopterori 10, Herba Duchesneae Indicae 30, little red Bulbus Allii root 10, Rhizoma Chuanxiong 15, Rhizoma Sparganii 6, Rhizoma Curcumae 15, Huechys sanguinea De Geer. 30, Radix Aristolochiae Kaempferi 6, Herba Artemisiae Anomalae 10, Radix Tinosporae 30, Herba Houttuyniae 3, Radix seu folium abelmoschi moschati 10, Aster oreophilus Franch 6, Herba Catharanthi Rosei 3, Nidus Vespae 30, Herba Polygoni cymosi 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310001820.8A CN103071112B (en) | 2013-01-05 | 2013-01-05 | Traditional Chinese medicine for curing nasopharynx cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310001820.8A CN103071112B (en) | 2013-01-05 | 2013-01-05 | Traditional Chinese medicine for curing nasopharynx cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103071112A CN103071112A (en) | 2013-05-01 |
| CN103071112B true CN103071112B (en) | 2014-05-07 |
Family
ID=48147957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310001820.8A Expired - Fee Related CN103071112B (en) | 2013-01-05 | 2013-01-05 | Traditional Chinese medicine for curing nasopharynx cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103071112B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108567917A (en) * | 2018-05-23 | 2018-09-25 | 杜美丽 | A kind of antitumor Chinese and the toxin expelling therapy that gasifies |
| CN108743814A (en) * | 2018-08-14 | 2018-11-06 | 骆漫 | A kind of preparation method of anti-nasopharyngeal carcinoma Chinese medicine composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102048940A (en) * | 2009-11-05 | 2011-05-11 | 天津太平洋制药有限公司 | Chinese medicinal preparation for treating chronic hepatitis and preparation method thereof |
| CN101757566A (en) * | 2010-04-07 | 2010-06-30 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating colon cancer and preparation method thereof |
-
2013
- 2013-01-05 CN CN201310001820.8A patent/CN103071112B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103071112A (en) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103655979A (en) | Traditional Chinese medicine composition for treating conjunctivitis | |
| CN103385331A (en) | Herbal tea | |
| CN104147359A (en) | Traditional Chinese medicine granule for relieving cough and resolving phlegm and preparation method thereof | |
| CN103071112B (en) | Traditional Chinese medicine for curing nasopharynx cancer | |
| CN103550414A (en) | Traditional Chinese medicine formula for treatment of prostatitis | |
| CN104248712A (en) | Cough relieving and phlegm resolving traditional Chinese medicine particle electuary and preparation method thereof | |
| CN102872250B (en) | Lotion for treating eczema | |
| CN102284053B (en) | Foot bathing preparation for treating insomnia | |
| CN102631450B (en) | Traditional Chinese medicine (TCM) decoction for treating wind-cold type common cold | |
| CN102698108A (en) | Jasmine golden camellia | |
| CN103071099B (en) | Traditional Chinese medicine for treatment of lung cancer by pink reineckea herb | |
| CN104740392A (en) | Traditional Chinese medicine for treating wind-heat type common cold | |
| CN105395868A (en) | Traditional Chinese medicinal composition for treating bronchitis | |
| CN104127645A (en) | Traditional Chinese medicament with effects of removing slough and promoting growth of tissue regeneration and preparation method thereof | |
| CN104491123A (en) | Cold treatment medicine | |
| CN104306761A (en) | Granules for treating cold and preparation method thereof | |
| CN103989904A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN103055214B (en) | Traditional Chinese medicine for treating nasopharynx cancer by utilizing lepidogrammitis intermedia | |
| CN103055215B (en) | Traditional Chinese herba preparation for treating nasopharyngeal carcinoma by seselopsis tianschanicum schischk | |
| CN102370863B (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN105477607A (en) | Tea for cold | |
| CN105456884A (en) | Traditional Chinese medicine composition for treating qi deficiency | |
| CN104225177A (en) | Traditional Chinese medicine for treating kidney vacuity and marrow depletion type tinnitus cerebri | |
| CN104083612A (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis | |
| CN103976071A (en) | Lung-heat-clearing and dryness-moistening tea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140507 Termination date: 20170105 |